Skip to content

A Comparative Clinical Trial Assessing Nanohydroxyapatite Dentifrice, Gluma Desensitizer, and Diode Laser Therapy in Dentinal Hypersensitivity .

COMPARATIVE EVALUATION OF NANOHYDROXYAPATITE DENTRIFICE, GLUMA DESENSITIZER AND DIODE-LASER IN REDUCING DENTINAL HYPERSENSITIVITY- AN IN-VIVO STUDY. - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108553
Enrollment
69
Registered
2026-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: GROUP 1: Use of HYDENT DUO desensitizing toothpaste : GROUP 1: Use of HYDENT DUO desensitizing toothpaste Patients will be given nanohydroxyapatite containing toothpaste HYDENT DUO and

Sponsors

Dr Chaitali Doshi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Non-carious cervical lesions in anterior and premolar teeth. Age group of 18-55 yrs (males and females) Good general health without any known allergy to commercial dental products. The degree of tooth initial hypersensitivity should be 2 or higher based on VAS score (0-10) before start of the treatment.

Exclusion criteria

Exclusion criteria: Non-vital teeth, carious teeth, restored teeth and patients who underwent desensitizing therapy or whitening treatment previously

Design outcomes

Primary

MeasureTime frame
Outcome is to compare and evaluate reduction in Dentinal Hypersensitivity assessed by air and cold water using Visual Analog Scale(VAS). Timepoint: Baseline and after 1 month from baseline

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Chaitali Mahendra Doshi

Chhattisgarh Dental College and Research Institute, Rajnandgaon

rashmi.a.nair@gmail.com9630145664

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026